Newsroom
Category
January 5, 2023
Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Written by Julie Collins of UT Health San Antonio and the Consortium to Alleviate PTSD (CAP) Network. SAN ANTONIO (January 5, 2023) – Study findings out today in JAMA Network Open show an important step forward in treating the psychological injuries of war. Researchers report that treatment for combat-related post-traumatic stress […]
December 20, 2022
The Mays Cancer Center at UT Health San Antonio — South Texas’ only National Cancer Institute-Designated Cancer Center — is putting a decades-old antidepressant drug to new use treating breast cancers that don’t respond to existing therapies. Research in the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio provided […]
December 15, 2022
American Federation for Aging Research grant allows exploration of signaling molecules toxic in Alzheimer’s, diabetes, aging Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Dec. 15, 2022) — The American Federation for Aging Research (AFAR) selected Juan Pablo Palavicini, PhD, an early career scientist at The University of Texas Health Science Center at San Antonio (UT […]
December 14, 2022
Recipient of American Academy of Nursing’s highest honor continues inclusion push Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu Content contributed by Rosanne Fohn SAN ANTONIO, Dec. 14, 2022 – During her more than 50-year nursing career, Norma Martínez Rogers focused on mentoring, nursing education, advocating for underserved populations and health care policy changes. But she never forgot […]
December 13, 2022
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO – The Living Beyond Cancer A-Z: A Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center Symposium, featuring a full day of learning, empowerment and discovery, will be held Jan. 21 at UT Health San Antonio Long School of Medicine’s Holly Auditorium. “For cancer survivors, […]
December 13, 2022
Vaccines for this infection have been challenging to produce SAN ANTONIO (Dec. 13, 2022) — The University of Texas Health Science Center at San Antonio has granted an exclusive global license allowing an Ohio biopharmaceutical company to develop university research discoveries into a novel oral vaccine for chlamydia. According to the U.S. Centers for Disease […]
